Premature Ovarian Failure Clinical Trial
Official title:
Transplantation of Specific Populations of Bone Marrow-Derived Stem Cells and Mesenchymal Stem Cells for the Treatment of Premature Ovarian Failure.
This is an open label, single arm, single center investigation to assess the safety and efficacy of purified adult autologous bone marrow derived specific populations of stem cells and mesenchymal stem cells injected into the ovaries (intraovarian injection), through a 12 week follow-up period. The investigators' chosen model of study is based on increasing the efficiency of the approach by choosing an autologous model which preserves the genetic composition of an individual that is vital in infertility conditions. Additionally the approach involves transplanting a combination of specific purified stem cell types which all aid in ovarian function recovery.
Premature ovarian failure (POF) is characterized as hypergonadotropic ovarian failure mostly
prevalent before age 40. It is astonishingly frequent and affects around 1% of women below
the age of 40. The clinical findings include amenorrhea and abnormally high levels of
luteinizing (LH) and follicle stimulating hormone (FSH). The etiology of POF is unidentified
in the majority of cases. It can occur due to a combination of genetics, immunological
diseases, and environmental factors. POF is characterized by lack of secondary follicles,
arrested folliculogenesis, decreased estrogen levels, and female infertility.
Currently, no available therapeutic intervention has been verified effective in retrieving
fertility in patients with POF. Several trials at ovarian stimulation are typically
ineffective. Consequently, the diagnosis of POF can cause great physical and emotional
distress among patients. Hence, there is serious need to develop innovative treatment plans
for POF.
The latest research shows that reduced ovarian reserve is caused by aging of the niche rather
than a defect in germ cell lines. Current scientific evidence suggests that bone
marrow-derived mesenchymal stem cells (BMSCs) could repair injured tissues and holds great
promise in treating many diseases including male and female infertility.
The uniqueness of this study is demonstrated in the transplantation of purified specific
populations of autologous bone marrow derived stem cells and mesenchymal stem cells (BMSCs)
into patients with POF without in vitro expansion or culture, with minimal manipulation. Stem
cells are withdrawn and transplanted back into the patient on the same day of the procedure,
thus presenting the highest safety and efficacy parameters.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Unknown status |
NCT01853501 -
Effects of ADSC Therapy in Women With POF
|
Phase 4 | |
| Completed |
NCT00417066 -
Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders
|
Phase 4 | |
| Active, not recruiting |
NCT04675970 -
Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy
|
||
| Recruiting |
NCT03480412 -
Second Step Protocol in Poor Ovarian Responder (POR)
|
||
| Completed |
NCT02644447 -
Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF
|
Phase 1/Phase 2 | |
| Completed |
NCT03840824 -
Blood Spot Self-administered Test and Assay
|
||
| Recruiting |
NCT00119925 -
'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists"
|
N/A | |
| Recruiting |
NCT06117982 -
The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency
|
Phase 2 | |
| Suspended |
NCT03816852 -
The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency
|
Phase 2 | |
| Not yet recruiting |
NCT04390308 -
Is There A Role For Mechanical Stimulation In Ovarian Follicular Activation?
|
||
| Completed |
NCT02783937 -
Filgrastim for Premature Ovarian Insufficiency
|
Phase 4 | |
| Completed |
NCT00295087 -
X-Chromosome Inactivation Status and Premature Ovarian Failure
|
N/A | |
| Completed |
NCT00429494 -
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
|
Phase 2 | |
| Not yet recruiting |
NCT05522634 -
A Clinical Study of Chinese Herbal Compound TJAOA101 in the Treatment of Premature Ovarian Insufficiency
|
Early Phase 1 | |
| Recruiting |
NCT05838157 -
The Effect of HPV Vaccine on Menstrual Cycle in Women of Reproductive Age
|
||
| Withdrawn |
NCT01129947 -
The Use of DHEA in Women With Premature Ovarian Failure
|
Phase 0 | |
| Completed |
NCT00001275 -
Ovarian Follicle Function in Patients With Primary Ovarian Failure
|
N/A | |
| Not yet recruiting |
NCT04306185 -
Ovarian Fragmentation Study (Crespo Medical Team)
|
N/A | |
| Recruiting |
NCT02062931 -
Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure
|
Phase 1/Phase 2 | |
| Completed |
NCT02151890 -
Pregnancy After Stem Cell Transplantation in Premature Ovarian Failure
|
Phase 1/Phase 2 |